Alzheimer's disease (10), diabetes, and several types of cancers have been linked to abnormal levels or behavior of O-GlcNAc, OGT, and OGA (5, 9–16). This evidence concerns the gene OGT and early-onset autosomal dominant Alzheimer disease.